Intraday Info: Insulet Corporation (NASDAQ:PODD) locked on 13/01/2017 at $43.55. It has average volume 616,665 whilst it totals volume 1.76M. The company has EPS -0.80 and according to analysts next quarter EPS and next year estimate EPS will -0.05 and -0.16 respectively. Profit Margin of PODD -13.00% and it total income 45.40 million.
Ownership Summary: Insulet Corporation has total institutional ownership 106.95% while its total outstanding shares 57 millions that’s value of holdings $2,675 million.
Active Positions: In the latest year, PODD 96 holders have raised its positions while it contains total 6,105,437 shares. And the strength of reduced positions holders and held positions holders are 80 and 21 respectively.
New and Sold Out Positions: In PODD force of new positions holders 37 and it has total shares 1,858,802. And force of sold out positions holders 17 and it has 1,214,784 shares.
Comparison with Other Company: The Market Value of PODD is $2M below from Boston Scientific Corporation market value which is $32M. Current Last Sale of PODD is $40.13 above from BSX current last sale which is $23.52.
Insulet enterprise offers OmniPod Insulin management machine (OmniPod machine), which includes the OmniPod, a smooth-to-use continuous insulin transport machine for humans with insulin-structured diabetes; and private diabetes manager, a handheld wireless tool. It also sells blood glucose testing elements, insulin pumps, pump components, prescription drugs, and different products for the administration and remedy of diabetes. The agency sells and markets its OmniPod machine via an aggregate of direct income representatives and impartial vendors.